Rigel Pharmaceuticals announces 1-for-10 reverse stock split effective June 27, 2024

RIGEL PHARMACEUTICALS INC

Reverse stock split at 1-for-10 ratio, reducing shares from ~175.6M to ~17.6M.
Effective June 27, 2024 at 12:01 a.m. ET; trading begins on split-adjusted basis same day.
Board approved final ratio on June 15, 2024, following stockholder approval on May 24, 2024.
Primary goal: raise per-share price to improve marketability and maintain Nasdaq $1 minimum bid compliance.
No fractional shares; cash in lieu paid. Authorized shares and par value unchanged.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.